Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Newamsterdam Pharma Company ORDINARY SHARES | 15,916,418 | 16,116,418 | +200,000 | $409.05M | $329.90M | 15.08% | -$79.15M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 6,570,392 | 6,795,121 | +224,729 | $271.69M | $306.12M | 13.99% | +$34.43M |
| Verona Pharma PlcADS | 3,383,950 | 3,457,850 | +73,900 | $157.15M | $219.54M | 10.03% | +$62.39M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 8,785,284 | 8,785,284 | 0 | $122.38M | $137.40M | 6.28% | +$15.02M |
| BridgeBio Pharma, Inc.(BBIO) | 3,800,457 | 3,800,457 | 0 | $104.28M | $131.38M | 6.00% | +$27.10M |
| Krystal Biotech, Inc.(KRYS) | 788,460 | 688,460 | -100,000 | $123.52M | $124.13M | 5.67% | +$609.2K |
| Disc Medicine, Inc.(IRON) | 1,754,834 | 1,754,834 | 0 | $111.26M | $87.11M | 3.98% | -$24.15M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 1,587,527 | 1,397,527 | -190,000 | $87.90M | $71.79M | 3.28% | -$16.11M |
| Trevi Therapeutics, Inc.(TRVI) | 10,664,774 | 10,259,409 | -405,365 | $43.94M | $64.53M | 2.95% | +$20.59M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 10,109,279 | 10,109,279 | 0 | $82.09M | $63.39M | 2.90% | -$18.70M |
| Kalvista Pharmaceuticals Inc | 4,887,867 | 4,887,867 | 0 | $41.40M | $56.41M | 2.58% | +$15.01M |
| Maze Therapeutics, Inc.(MAZE) | 0 | 4,129,001 | +4,129,001 | $0 | $45.46M | 2.08% | +$45.46M |
| MBX Biosciences, Inc.(MBX) | 5,985,347 | 5,985,347 | 0 | $110.31M | $44.17M | 2.02% | -$66.14M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 1,869,808 | 678,760 | -1,191,048 | $104.67M | $35.95M | 1.64% | -$68.72M |
| Soleno Therapeutics Inc | 699,159 | 499,159 | -200,000 | $31.43M | $35.66M | 1.63% | +$4.24M |
| Revolution Medicines, Inc.(RVMD) | 997,455 | 997,455 | 0 | $43.63M | $35.27M | 1.61% | -$8.36M |
| Savara Inc.(SVRA) | 8,660,379 | 11,462,301 | +2,801,922 | $26.59M | $31.75M | 1.45% | +$5.16M |
| Agios Pharmaceuticals, Inc.(AGIO) | 1,069,754 | 1,069,854 | +100 | $35.15M | $31.35M | 1.43% | -$3.81M |
| Erasca, Inc.(ERAS) | 19,391,687 | 22,575,851 | +3,184,164 | $48.67M | $30.93M | 1.41% | -$17.74M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 658,715 | 658,715 | 0 | $27.71M | $23.85M | 1.09% | -$3.86M |
| Ascendis Pharma A/SADR(ASND) | 133,333 | 133,333 | 0 | $18.36M | $20.78M | 0.95% | +$2.43M |
| Vaxcyte, Inc.(PCVX) | 539,405 | 539,405 | 0 | $44.16M | $20.37M | 0.93% | -$23.79M |
| Alkermes plcSHS(ALKS) | 601,129 | 601,129 | 0 | $17.29M | $19.85M | 0.91% | +$2.56M |
| Palvella Therapeutics, Inc.(PVLA) | 653,892 | 690,012 | +36,120 | $7.85M | $19.31M | 0.88% | +$11.47M |
| CG Oncology, Inc.(CGON) | 770,000 | 770,000 | 0 | $22.08M | $18.86M | 0.86% | -$3.23M |
| Mereo BioPharma Group plcADS(MREO) | 5,097,779 | 7,819,863 | +2,722,084 | $17.84M | $17.59M | 0.80% | -$247.5K |
| Merus N V | 373,100 | 373,100 | 0 | $15.69M | $15.70M | 0.72% | +$14.9K |
| Avidity Biosciences Inc | 0 | 525,000 | +525,000 | $0 | $15.50M | 0.71% | +$15.50M |
| Hillevax Inc | 10,617,062 | 10,617,062 | 0 | $21.98M | $15.39M | 0.70% | -$6.58M |
| Dyne Therapeutics, Inc.(DYN) | 0 | 1,443,341 | +1,443,341 | $0 | $15.10M | 0.69% | +$15.10M |
| Zai Lab LimitedADR(ZLAB) | 0 | 350,000 | +350,000 | $0 | $12.65M | 0.58% | +$12.65M |
| Immunocore Holdings plcADS(IMCR) | 108,762 | 301,170 | +192,408 | $3.21M | $8.94M | 0.41% | +$5.73M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 3,888,238 | 1,410,193 | -2,478,045 | $31.38M | $7.87M | 0.36% | -$23.51M |
| Acadia Pharmaceuticals Inc | 470,338 | 470,338 | 0 | $8.63M | $7.81M | 0.36% | -$818.4K |
| Design Therapeutics, Inc.(DSGN) | 1,953,547 | 1,953,547 | 0 | $12.05M | $7.54M | 0.34% | -$4.51M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 1,479,025 | 1,079,025 | -400,000 | $18.59M | $7.20M | 0.33% | -$11.39M |
| Autolus Therapeutics plcADS(AUTL) | 4,623,324 | 4,623,324 | 0 | $10.86M | $7.17M | 0.33% | -$3.70M |
| Oruka Therapeutics, Inc.(ORKA) | 583,327 | 583,327 | 0 | $11.31M | $5.98M | 0.27% | -$5.33M |
| Allogene Therapeutics Inc | 2,867,750 | 3,868,750 | +1,001,000 | $6.11M | $5.65M | 0.26% | -$459.9K |
| Immatics N.V.SHS(IMTX) | 2,147,911 | 1,247,911 | -900,000 | $15.27M | $5.63M | 0.26% | -$9.64M |
| Cogent Biosciences, Inc.(COGT) | 936,576 | 936,576 | 0 | $7.31M | $5.61M | 0.26% | -$1.70M |
| Adverum Biotechnologies Inc | 1,069,244 | 1,069,244 | 0 | $4.99M | $4.67M | 0.21% | -$320.8K |
| Newamsterdam Pharma CompanyW EXP 99 99 999 *W EXP 99/99/999 | 500,333 | 500,333 | 0 | $7.13M | $4.50M | 0.21% | -$2.63M |
| MacroGenics, Inc.(MGNX) | 3,175,665 | 3,175,665 | 0 | $10.32M | $4.03M | 0.18% | -$6.29M |
| Lexeo Therapeutics, Inc.(LXEO) | 955,515 | 955,515 | 0 | $6.29M | $3.32M | 0.15% | -$2.97M |
| Silence Therapeutics plcADS(SLN) | 1,148,591 | 1,148,591 | 0 | $7.90M | $3.24M | 0.15% | -$4.66M |
| Elevation Oncology Inc | 5,993,579 | 5,993,579 | 0 | $3.37M | $1.55M | 0.07% | -$1.82M |
| 89bio Inc | 1,000,000 | 0 | -1,000,000 | $7.82M | $0 | — | -$7.82M |
| Anaptysbio Inc | 1,573,719 | 0 | -1,573,719 | $20.84M | $0 | — | -$20.84M |
| Arvinas, Inc.(ARVN) | 285,331 | 0 | -285,331 | $5.47M | $0 | — | -$5.47M |
| Day One Biopharmaceuticals I COM | 689,655 | 0 | -689,655 | $8.74M | $0 | — | -$8.74M |
| Edgewise Therapeutics, Inc.(EWTX) | 1,271,245 | 0 | -1,271,245 | $33.94M | $0 | — | -$33.94M |
| Eledon Pharmaceuticals, Inc.(ELDN) | 1,176,735 | 0 | -1,176,735 | $4.85M | $0 | — | -$4.85M |
| Pliant Therapeutics, Inc.(PLRX) | 1,120,803 | 0 | -1,120,803 | $14.76M | $0 | — | -$14.76M |